Standout Papers

Differential cytokine modulation and T cell activation by two distinct classes of thalidomide ... 1999 2026 2008 2017 629
  1. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. (1999)
    Laura G. Corral, Patrick Haslett et al. PubMed
  2. Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α (1999)
    Laura G. Corral, Patrick Haslett et al. The Journal of Immunology

Immediate Impact

6 by Nobel laureates 33 from Science/Nature 62 standout
Sub-graph 1 of 20

Citing Papers

Chemistry, structure and function of approved oligonucleotide therapeutics
2023 Standout
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
1 intermediate paper

Works of Patrick Haslett being referenced

MP12-14 SAFETY AND EFFICACY STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNA INTERFERENCE (RNAI) THERAPEUTIC, IN ADULT AND PEDIATRIC PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1)
2019
An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria
2016

Author Peers

Author Last Decade Papers Cites
Patrick Haslett 1231 393 781 1458 1455 56 4.3k
Thomas A. Fleisher 2176 227 608 1761 722 54 5.3k
Angélique Biancotto 1230 627 561 904 854 84 3.9k
Gregory R. Harriman 2732 68 651 1142 1536 37 7.2k
Carl O’Hara 992 738 1037 2221 417 106 5.7k
P Ralph 2876 203 381 2029 1314 77 5.9k
JE Groopman 1468 1561 752 607 1352 55 4.4k
Vito Racanelli 1997 155 1391 1629 792 148 6.3k
James N. Woody 2374 78 996 790 992 91 6.4k
Gabriele Köhler 1857 89 1299 1573 514 87 5.1k
Grover C. Bagby 1299 243 406 2617 1619 129 5.4k

All Works

Loading papers...

Rankless by CCL
2026